Abstract: A power machine includes a frame, an arm pivotally coupled to the frame, a power source supported on the frame, and an implement interface having an implement carrier pivotally coupled to the arm and configured to mount an implement on the power machine. The power source can be an electric power source, and the implement interface includes a power transfer system configured to provide power from the power source to the implement mounted on the implement carrier. The power transfer system of the implement interface can include a motor which rotates a power take-off output shaft in some embodiments. The power transfer system can include a hydraulic converter having a hydraulic reservoir and a hydraulic pump and configured to provide pressurized hydraulic fluid to the implement in some embodiments.

Abstract: The present disclosure relates to an electronic smoking article that provides for improved aerosol delivery. Particularly, the article comprises one or more microheaters. In various embodiments, the microheaters provide for improved control of vaporization of an aerosol precursor composition and provide for reduced power requirements to achieve consistent aerosolization. The present disclosure further relates to methods of forming an aerosol in a smoking article.

Abstract: A vapor-enhancing apparatus is provided for an electronic vapor smoking article. Such an apparatus includes a filter material and a tubular housing defining a lumen. The lumen has a mouth-engaging end and a longitudinally-opposed component-engaging end, and is configured to receive the filter material therein. The component-engaging end is adapted to operably engage a control body portion associated with the electronic vapor smoking article and to receive a vapor therethrough. A vapor-enhancing element is operably engaged with the filter material and is configured to enhance the vapor drawn through the filter material within the lumen, and through the mouth-engaging end, by application of suction to the mouth-engaging end of the housing. An associated method is also provided.

Abstract: The invention provides stable coronavirus spike proteins. Immunogenic compositions comprising same and the methods of using these immunogenic compositions are also provided.

Abstract: Attachment mechanisms for eyewear are shown and disclosed. In some embodiments, the eyewear includes a lens and a lens locking element fixedly attached to, or formed with the lens. The eyewear additionally includes a frame having at least one surface that contacts at least a portion of a perimeter of the lens. The eyewear additionally includes a frame locking assembly that includes a locking base attached to, or formed with, the frame. The frame locking assembly additionally includes a frame locking element that moves relative to the locking base. The lens locking element and the frame locking assembly are positioned such that, when the at least a portion of a perimeter of the lens contacts the at least one surface, the frame locking element mechanically engages the lens locking element to removably secure the lens to the frame.

Abstract: The instant invention provides various formulations comprising combinations of immunostimulating oligonucleotides, polycationic carriers, sterols, saponins, quaternary amines, TLR-3 agonists, glycolipids, and MPL-A or analogs thereof in oil emulsions, use thereof in preparations of immunogenic compositions and vaccines, and use thereof in the treatment of animals.

Abstract: A transparent bottle for holding a liquid includes a bottle body that includes a front wall, a rear wall and a first side wall and a second side wall that extend between the front wall and the rear wall. The first side wall includes a central portion and a front faceted portion that extends between the central portion and the front wall. The front faceted portion is curved relative to the central portion and is separated from the central portion by a front outer transition line and is separated from the front wall by a front inner transition line. A bottom that extends between the front wall, the rear wall and the first and second side walls. The bottom provides a base structure for supporting the bottle in an upright, standing position. A shoulder extends inward from the bottle body and a neck extends outward from the shoulder toward a mouth.

Abstract: The present disclosure generally relates to optical molecules, including but not limited to 1,3-thiazolidin-4-ones and other molecules comprising an aza-heterocyclic ring system containing a chalcogen. In some embodiments, the molecules may absorb light between 300 nm and 800 nm, e.g., appearing as various colors, depending on the absorbance. In some cases, the optical molecules can be used as color additives, pigments, dyes, or the like. Other embodiments of the disclosure are generally directed to systems and devices using such compounds, methods of using such compounds, kits involving such compounds, or the like.

Abstract: A contact tip assembly with a preheating tip comprises a welding-type power source configured to provide welding-type current to a welding-type circuit, the welding-type circuit comprising a welding-type electrode and a first contact tip of a welding torch; an electrode preheating circuit configured to provide preheating current through a first portion of the electrode via a second contact tip of the welding torch; and a preheat controller to: monitor a voltage drop across a second portion of the electrode; adjust at least one of the welding-type current or the preheating current based on the voltage drop, the second portion of the electrode comprising at least part of the first portion of the electrode; and control the preheating current based on a hydrogen reduction goal and based on stored parameters associated with a type of the electrode, a chemistry of the electrode, or a wire size.

Abstract: Compounds, tautomers and pharmaceutically acceptable salts of the compounds are disclosed, wherein the compounds have the structure of Formula Ia, as defined in the specification. In an embodiment, a pharmaceutical composition can be in a liquid dosage form and can comprise a therapeutically effective amount of the compound or a pharmaceutically acceptable salt thereof as an adjuvant and a therapeutic agent. In another embodiment, a method of adjuvant treating a disorder or condition can comprising administering the pharmaceutical composition to a patient.

Abstract: A system receives a selection, by a first entity, of product, provided by a second entity, wherein the first entity and the second entity are members of an entity network. The system receives an indication of receipt of the product via an application programming interface (API), transmitted by a first entity, and derives a first ranking metric for the second entity of the entity network based on feedback received from the first entity of the entity network. The system derives a second ranking metric for the second entity of the entity network based on one or more transactions received from a third entity of the entity network, determines whether the first ranking metric is valid based on the second ranking metric, and provides the first ranking metric to entities of the entity network based on the validity of the first ranking metric.

Abstract: The present disclosure relates to aerosol delivery devices. The aerosol delivery devices include mechanisms configured to deliver an aerosol precursor composition from a reservoir to an atomizer including a vaporization heating element to produce a vapor. For example, a bubble jet head may be configured to dispense the aerosol precursor composition to the atomizer. The bubble jet head may be fixedly coupled to the atomizer. The bubble jet head may include a precursor inlet, an ejection heating element, and a precursor nozzle. The atomizer may include a vaporization heating element.

Abstract: The present disclosure relates to aerosol delivery devices. The aerosol delivery devices include mechanisms configured to deliver an aerosol precursor composition from a reservoir to an atomizer including a vaporization heating element to produce a vapor. For example, a bubble jet head may be configured to dispense the aerosol precursor composition to the atomizer. The bubble jet head may be fixedly coupled to the atomizer. The bubble jet head may include a precursor inlet, an ejection heating element, and a precursor nozzle. The atomizer may include a vaporization heating element.

Abstract: A transparent bottle for holding a liquid includes a bottle body that includes a front wall, a rear wall and a first side wall and a second side wall that extend between the front wall and the rear wall. The first side wall includes a central portion and a front faceted portion that extends between the central portion and the front wall. The front faceted portion is curved relative to the central portion and is separated from the central portion by a front outer transition line and is separated from the front wall by a front inner transition line. A bottom that extends between the front wall, the rear wall and the first and second side walls. The bottom provides a base structure for supporting the bottle in an upright, standing position. A shoulder extends inward from the bottle body and a neck extends outward from the shoulder toward a mouth.

Abstract: The present invention describes articles, such as smoking articles, that can provide an inhalable substance in a form suitable for inhalation by a consumer. The article comprises a cartridge with an inhalable substance medium therein, control housing that includes an electrical energy source and an electrical power source, and a heating member that may be located in either the cartridge or the control housing. The control housing further may include puff-actuated current actuation components and current regulation components.

Abstract: The present invention provides for an apparatus and a method for automating the dispensing a liquid agent into a toilet.